Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Berendt

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
World Journal of Surgical Oncology|June 28, 2012
Outcome analysis of breast cancer patients who declined evidence-based treatmentKurian Joseph, Sebastian Vrouwe, Anmmd Kamruzzaman, et al.
BMC Genomics|September 30, 2015
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancerPreethi Krishnan, Sunita Ghosh, Bo Wang, et al.
Journal of Clinical Pathology|January 25, 2011
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experienceMaria Copete, John Garratt, Blake Gilks, et al.
American Journal of Clinical Pathology|February 16, 2010
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests, Emina Emilia Torlakovic, Robert Riddell, et al.
BMJ Open|September 19, 2019
Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trialMarnie Newell, John R Mackey, Gilbert Bigras, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ImmunohistochemistryJefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
World Journal of Surgical Oncology|June 28, 2012
Outcome analysis of breast cancer patients who declined evidence-based treatmentKurian Joseph, Sebastian Vrouwe, Anmmd Kamruzzaman, et al.
BMC Genomics|September 30, 2015
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancerPreethi Krishnan, Sunita Ghosh, Bo Wang, et al.
Journal of Clinical Pathology|January 25, 2011
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experienceMaria Copete, John Garratt, Blake Gilks, et al.
American Journal of Clinical Pathology|February 16, 2010
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests, Emina Emilia Torlakovic, Robert Riddell, et al.
BMJ Open|September 19, 2019
Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trialMarnie Newell, John R Mackey, Gilbert Bigras, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ImmunohistochemistryJefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Pageof 2